Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Catalent Biologics’ Paragon Gene…
Super UserJuly 1, 2019
As the dominant economic geography of America, metropolitan statistical areas largely determine our success as a nation. These groups of…
Super UserJuly 1, 2019
Adaptive Biotechnologies has raised the price for its initial public offering, putting itself in a position to raise more cash…
Super UserJuly 1, 2019
Health Tech early stage (below $10 million) investing grew consistently from 2010 - 2017, but then stalled in 2018 showing…
Super UserJuly 1, 2019
The company that makes Botox is the subject of the latest biopharma mega-deal. Chicago-based AbbVie said Tuesday it would acquire…
Super UserJuly 1, 2019
At the end of November in Washington, D.C., Children's National Health System began work on a historical renovation construction project…
Super UserJuly 1, 2019
The Pinkney Innovation Complex for Science and Technology (PIC MC) signed a development agreement today to add a state-of-the-art life…
Super UserJune 24, 2019
Investigators at the University of Central Florida (UCF) have just identified the molecular changes that happen when neuronal stem cells…
Super UserJune 24, 2019
Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) announced today the pricing of its upsized public offering…
Super UserJune 24, 2019